在肺状细胞癌中解读瘤免疫微环境:特征,调控机制和免疫治疗的未来方向
Yunfeng Tong1,2, Yuxia Wang1,2, Yunfei Chen1,2
1Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
Translational lung cancer research
|October 24, 2025
概括
肺状细胞癌 (LUSC) 治疗是具有挑战性的,因为其复杂的瘤免疫微环境 (TIME). 了解LUSC TIME异质性是改善免疫疗法反应和患者结果的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 肺状细胞癌 (LUSC) 预后不好,治疗选择有限,与肺腺癌 (LUAD) 不同.
- 免疫疗法只对一小部分LUSC患者有益,结果受到瘤免疫微环境 (TIME) 的影响.
- 卢斯克时代是一个动态的生态系统,促进免疫逃避和对治疗的抵抗.
研究的目的:
- 审查LUSC瘤免疫微环境 (TIME) 的特征和调节机制.
- 建立一个新的分类时间为LUSC患者分层.
- 突出针对LUSC免疫学背景的潜在免疫治疗策略.
主要方法:
- 综述了多组学技术的最新进展,包括单细胞RNA测序 (scRNA-seq) 和空间组学.
- 在LUSC时间内分析细胞和分子结构.
- 检查免疫细胞种群及其与瘤的空间相互作用.
主要成果:
- 多omics技术为LUSC TIME复杂性提供了高分辨率的见解.
- 识别不同的免疫细胞及其空间相互作用,有助于免疫逃避.
- 为LUSC提出了一个新的TIME分类框架.
结论:
- 了解LUSC TIME异质性对于预测免疫治疗反应至关重要.
- 拟议的TIME分类可以为LUSC患者指导个性化免疫疗法策略.
- 对LUSC TIME机制的进一步研究可以揭示新的治疗点.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K